πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 401 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9499606

Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9486509

Compositions and methods for preparing a subject for organ or non-organ implantation

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9480673

Composition and method for treating neurodegenerative disease

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Nov 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 27 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9474784

Therapeutic applications of SMAD7

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9457070

Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marro

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9456997

Selective inhibition of Ξ²1-adrenergic receptors for the treatment of pediatric heart failu

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9452215

Bourvadin derivatives and therapeutic uses thereof

The Regents of the University of Colorado Β· Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9447406

Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9422340

Macrocyclic compounds useful as inhibitors of histone deacetylases

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9422352

PTD-SMAD7 therapeutics

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9409880

Modulators of TLR3/dsRNA complex and uses thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9402881

Tissue regeneration and wound treatment methods with platelet derived compositions

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9387245

Methods and compositions for the inhibition of fructokinase

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9372186

Minimally-invasive measurement of esophageal inflammation

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9352015

Antimicrobial peptides

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9345726

CD117+ cells and uses thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9346865

Antimicrobial peptides and methods of use

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9321820

Compositions and methods for treating bladder cancer

The Regents of the University of Colorado Β· Granted Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9295674

Metalloporphyrin neurological treatments

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Mar 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9290562

Transferrin-tumstatin fusion protein and methods for producing and using the same

The Regents of the University of Colorado Β· Granted Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9284546

Human cystathionine beta-synthase variants and methods of production thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Mar 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9259488

Anti-C3d antibody conjugates and methods of detecting complement activation

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9243239

Purification of cystathionine beta-synthase

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9212212

Targeting complement factor H for treatment of diseases

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted